Poređenje ishoda lečenja pacijenata podvrgnutih TUR sa pacijentima lečenim BCG imunoterapijom nakon TUR -preliminarni rezutati

Perica Jockic ,
Perica Jockic
Nikola Kolarevic ,
Nikola Kolarevic
Dragan Grebenarovic ,
Dragan Grebenarovic
Sasa Mazibrada ,
Sasa Mazibrada
Bora Cvetkovic ,
Bora Cvetkovic
Aleksandar Argirovic ,
Aleksandar Argirovic
Aleksandar Antic ,
Aleksandar Antic
Goran Potpara ,
Goran Potpara
Milenko Stanic ,
Milenko Stanic
Vuk Aleksic
Vuk Aleksic

Published: 01.12.2014.

Biochemistry

Volume 31, Issue 2 (2015)

pp. 1293-1298;

https://doi.org/10.5937/matmed1502293j

Abstract

Keywords

References

1.
Anastasiadis A, De Reijke T. Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv urol. 2012;(1):13–32.
2.
Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A, et al. Cancer statisics. CA Cancer J Clin. 2005;(1):10–30.
3.
Aldousari S, Kassouf W. Update on the management of non-muscle invasive baldder cancer. Can Urol Assoc J. 2010;(1):56–64.
4.
Nour H, Gobashy S, Kamal A, Elbaz A, Roshdy M, Kamel A. Low-dose bacilleCalmette-Guérin for nonmuscle-invasive bladder cancer: Results of a prospective study. Arab J Urol. 2015;(4):238–43.
5.
Sfakianos J, Shariat S, Favaretto R, Rioja J, Herr H. Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder. BJU Int. 2011;(4):526–30.
6.
Mohr D, Offord K, Owen R, Melton R. Asymptomatic microhematuria and urologic disease. A population based study. JAMA. 1986;224–9.
7.
Dershaw D, Panicek D. Imaging of invasive bladder cancer. Semin Oncol. 1990;544–50.
8.
Fuller S, J. Staging of advanced bladder cancer: current concepts and pitfalls. Urol Clin Corth Am. 1992;663–83.
9.
Brandau S, Suttman H. Thirty years of BCG immunotherapy for nonmuscle invasive bladder cancer: a success story with room for improvement. Biomed Pharmacother. 2007;229–305.
10.
Gontero P, Bohle A, Malmstorm P, Donnell O, Oderda M, Dylvester M, et al. The role of bacillus Calmette-Guerin in the treatment of non musle invasive bladder cancer. 2010;410–29.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners